Jack W. Callicutt - Nov 5, 2025 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Signature
Jack W. Callicutt
Stock symbol
GALT
Transactions as of
Nov 5, 2025
Transactions value $
-$2,638
Form type
4
Date filed
11/7/2025, 04:07 PM
Previous filing
Nov 5, 2025
Next filing
Nov 12, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CALLICUTT JACK W Chief Financial Officer C/O GALECTIN THERAPEUTICS INC., 4960 PEACHTREE INDUSTRIAL BLVD., STE 240, NORCROSS Jack W. Callicutt 2025-11-07 0001266773

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GALT Common stock Options Exercise $396 +200 +2.63% $1.98 7.81K Nov 5, 2025 Direct F1
transaction GALT Common stock Sale -$1.2K -200 -2.56% $6.00 7.61K Nov 5, 2025 Direct F1
transaction GALT Common stock Options Exercise $222 +200 +2.63% $1.11 7.81K Nov 5, 2025 Direct F1
transaction GALT Common stock Sale -$1.2K -200 -2.56% $6.00 7.61K Nov 5, 2025 Direct F1
transaction GALT Common stock Options Exercise $344 +200 +2.63% $1.72 7.81K Nov 5, 2025 Direct F1
transaction GALT Common stock Sale -$1.2K -200 -2.56% $6.00 7.61K Nov 5, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GALT Stock option (right to buy) Options Exercise $0 -200 -0.5% $0.00 39.6K Nov 5, 2025 Common stock 200 $1.98 Direct F1, F2
transaction GALT Stock option (right to buy) Options Exercise $0 -200 -0.5% $0.00 39.6K Nov 5, 2025 Common stock 200 $1.11 Direct F1, F3
transaction GALT Stock option (right to buy) Options Exercise $0 -200 -0.38% $0.00 52.8K Nov 5, 2025 Common stock 200 $1.72 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on April 17, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.
F2 The options vested as follows: 25% on each of June 30, 2022, December 31, 2022, June 30, 2023, and December 31, 2023.
F3 The options vested as follows: 25% on each of June 30, 2023, December 31, 2023, June 30, 2024, and December 31, 2024.
F4 The options vested as follows: 25% on each of June 30, 2024, December 31, 2024, and June 30, 2025, with 25% scheduled to vest on December 31, 2025.